| Document Date: 2014-05-20 20:17:39
Open Document File Size: 167,55 KBShare Result on Facebook
Company Novartis New Zealand Limited / Affairs & Quality Assurance Manager Novartis New Zealand Ltd Pharmaceuticals / / Country Canada / / / Event Product Issues / Product Recall / FDA Phase / / / IndustryTerm treatment of osteoarthritis / healthcare / food / / MedicalCondition liver dysfunction / i.e. nausea / chronic treatment / Liver failure / chronic use / osteoarthritis / pain / vomiting / induced hepatitis / tiredness / liver disease / acute gout / / Organization Centre for Adverse Reactions Monitoring / European Union / / Person Peter Sharpe Martyn Gillam / Martyn Gillam / / / Position Assurance Manager / General Manager / / Product ibuprofen / Prexige 400 mg / naproxen / 400mg / Prexige™ (lumiracoxib) tablets / / Region Latin America / / Technology transplantation / /
SocialTag |
Microsoft Word - Healthcare_Professional_Letter_19Aug07.doc